Division of Pediatric Epidemiology and Clinical Research, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota.
Brain Tumor Program, University of Minnesota, Minneapolis, Minnesota.
Cancer Epidemiol Biomarkers Prev. 2022 Sep 2;31(9):1830-1838. doi: 10.1158/1055-9965.EPI-21-0997.
Recent investigations of malignant peripheral nerve sheath tumor (MPNST) survival have reported higher mortality among non-White individuals. However, previous analyses have not examined the impact of socioeconomic status (SES) on these observations. This study aims to characterize factors associated with cause-specific MPNST survival, including information related to census-tract-level SES (CT-SES).
We identified 2,432 primary MPNSTs using the Surveillance, Epidemiology, and End Results (SEER) 18 (2000-2016) database. We used Cox proportional hazards modeling to estimate the effects of sex, race/ethnicity, CT-SES quintile, metastasis at diagnosis, tumor site, age at diagnosis, and treatment by surgery on survival. Models were fit in both the full population and, separately, stratified by race/ethnicity and age at diagnosis (<40 vs. ≥40).
In adjusted models, age at diagnosis, CT-SES, and metastasis at diagnosis were associated with mortality. In race/ethnicity-stratified analysis, higher CT-SES was found to improve survival only in the White population. Among those diagnosed before age 40, metastasis at diagnosis and American Indian/Alaska Native race/ethnicity were associated with mortality, and both Hispanic ethnicity and Asian/Pacific Islander race were suggestive for increased mortality. Among cases, diagnoses at age 40 and above, age at diagnosis, male sex, and CT-SES were associated with mortality.
This analysis provides evidence that among pediatric and young adult patients, non-White populations experience inferior survival compared with Whites, independent of CT-SES. Our findings also suggest that the effect of CT-SES on MPNST survival may differ by racial/ethnic group.
These findings suggest that barriers to healthcare for certain racial/ethnic groups extend beyond SES.
最近对恶性外周神经鞘瘤(MPNST)生存的研究报告称,非白人个体的死亡率更高。然而,之前的分析并未检查社会经济地位(SES)对这些观察结果的影响。本研究旨在描述与特定原因的 MPNST 生存相关的因素,包括与普查地段级 SES(CT-SES)相关的信息。
我们使用监测、流行病学和最终结果(SEER)18 数据库(2000-2016 年)确定了 2432 例原发性 MPNST。我们使用 Cox 比例风险模型来估计性别、种族/族裔、CT-SES 五分位数、诊断时转移、肿瘤部位、诊断时年龄和手术治疗对生存的影响。模型在全人群中以及分别按种族/族裔和诊断时年龄(<40 与≥40)进行分层进行拟合。
在调整后的模型中,诊断时年龄、CT-SES 和诊断时转移与死亡率相关。在按种族/族裔分层的分析中,发现较高的 CT-SES 仅能改善白人人群的生存。在诊断年龄小于 40 岁的人群中,诊断时转移和美洲印第安人/阿拉斯加原住民种族/族裔与死亡率相关,而西班牙裔和亚洲/太平洋岛民种族与死亡率增加相关。在诊断年龄在 40 岁及以上的病例中,诊断时年龄、男性性别和 CT-SES 与死亡率相关。
本分析提供的证据表明,在儿科和年轻成年患者中,非白人人群的生存状况不如白人,独立于 CT-SES。我们的研究结果还表明,CT-SES 对 MPNST 生存的影响可能因种族/族裔群体而异。
这些发现表明,某些种族/族裔群体获得医疗保健的障碍不仅限于 SES。